The neurobiology of attention-deficit/hyperactivity disorder

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 7, 1998, Pages 17-23

  Zametkin, Alan J ^a   Liotta, Wendi ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NORADRENALIN; SEROTONIN; THYROID HORMONE RECEPTOR;

ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN; COMPUTER ASSISTED TOMOGRAPHY; GENETICS; HUMAN; NEUROCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGICAL THEORY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASAL GANGLIA; BRAIN; FEMALE; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031870219     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bergstrom K, Bille B. Computer tomography of the brain in children with minimal brain damage: a preliminary study of 46 children. Neuropadiatrie 1978;9:378-384
2. Nasrallah HA, Loney J, Olsen SC, et al. Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry Res 1986;17: 241-246
3. Shaywitz BA, Shaywitz SE, Byrne T, et al. Attention deficit disorder: quantitative analysis of CT. Neurology 1983;33:1500-1503
4. Epstein P, Pisani V, Fawcett J. Alcoholism and cerebral atrophy. Alcohol Clin Exp Res 1977;1:61-65
5. Hynd GW, Semrud-Clikeman M, Lorys AR, et al. Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity. Arch Neurol 1990;47:919-226
6. Hynd GW, Semrud-Clikeman M, Lorys AR, et al. Corpus callosum morphology in attention deficit hyperactivity disorder: morphometric analysis of MRI. Journal of Learning Disabilities 1991;24:141-146
7. Giedd JN, Castellanos FX, Casey BJ, et al. Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry 1994;151:665-669
8. Hynd GW, Hern KL, Novey ES, et al. Attention deficit hyperactivity disorder and asymmetry of caudate nucleus. J Child Neurol 1993;8:339-347
9. Castellanos FX, Giedd JN, Eckburg P, et al. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder Am J Psychiatry 1994;151:1791-1796
10. Castellanos FX, Giedd JN, Marsh WL, et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996;53:607-616
11. Rubia K. Inhibitory control of hyperactive adolescents in fMRI. Presented at the Royal College of Psychiatrist Annual Meeting; January 24, 1997; Cardiff, Wales
12. Amen D. Brain SPECT imaging in ADHD [letter]. J Am Acad Child Adolesc Psychiatry 1993;5;1079-1080
13. Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990;323: 1361-1366
14. Zametkin AJ, Liebenauer LL, Fitzgerald GA, et al. Brain metabolism in teenagers with attention deficit hyperactivity disorder. Arch Gen Psychiatry 1993;50:333-340
15. Ernst M, Liebenauer LL, King AC, et al. Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry 1994;33:858-868
16. Matochik JA, Nordhal TE, Gross M, et al. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity. Neuropsychopharmacology 1993;8:377-386
17. Matochik JA, Liebenauer LL, King AC, et al. Cerebral glucose metabolism in adults with attention-deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry 1994;151:658-664
18. Volkow ND, Ding YS, Fowler JS, et al. Is methylphenidate like cocaine? studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995;52:456-463
19. Volkow ND, Ding Y, Fowler JS, et al. A new PET ligand for the dopamine transporter: studies in the human brain. J Nucl Med 1995;36:2162-2168
20. Deutsch CK, Matthysse S, Swanson JM, et al. Genetic latent structure analysis of dysmorphology in attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990;29:189-194
21. Faraone SV, Biederman J, Chen WJ, et al. Segregation analysis of attention deficit-hyperactivity disorder: evidence for single gene transmission. Psychiatr Genet 1992;2:257-275
22. Morrison JR, Stewart MA. The psychiatric status of the legal families of adopted hyperactive children. Arch Gen Psychiatry 1973;28:888-891
23. Cantwell DP. Psychiatric illness in the families of hyperactive children. Arch Gen Psychiatry 1972;27:414-417
24. Safer D. A familial factor in minimal brain dysfunction. Behav Genet 1973; 3:175-186
25. Goodman R, Stevenson J. A twin study of hyperactivity, II: the aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiatry 1989;30:691-709
26. Stevenson J, Pennington BF, Gilger JW, et al. Hyperactivity and spelling disability: testing for shared genetic aetiology. J Child Psychol Psychiatry 1993;34:1137-1152
27. Biederman J, Faraone SV, Keenan K, et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992;49:728-738
28. Hauser P, Zametkin AJ, Martinez P, et al. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 1993;328:997-1001
29. Weiss R, Stein M, Trommer B, et al. Attention-deficit hyperactivity disorder and thyroid function. J Pediatr 1993;123:539-545
30. Cook EH Jr, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56:993-998
31. Weiss R, Stein M, Duck S, et al. Low intelligence but not attention deficit hyperactivity disorder is associated with resistance to thyroid hormone caused by mutation R316H in the thyroid hormone receptor ß gene. J Clin Endocnnol Metab 1994;78:1525-1528
32. Lahoste GF, Swanson JM, Wigal SB. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry 1996;1(2):121-124
33. Zametkin AJ, Rapoport JL. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? Am Acad Child Adolesc Psychiatry 1987;26:676-686
34. Rogeness GA, Javors MA, Pliska SR. Neurochemistry and child and adolescent psychiatry. Am Acad Child Adolesc Psychiatry 1992;31:765-781
35. Oades RD. Attention deficit disorder with hyperactivity (ADDH): the contribution of catecholaminergic activity. Prog Neurobiol 1987;29:365-391
36. Mefford IN, Potter WZ. A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a deficit in tonic adrenaline mediated inhibition of locus coeruleus stimulation. Med Hypotheses 1989;29:33-42
37. Voeller KK. What can neurological models of attention, inattention, and arousal tell us about attention deficit hyperactivity disorder. J Neuropsychiatry Clin Neurosci 1991;3:209-216
38. McCracken JT. A two-part model of stimulant action on attention-deficit hyperactivity disorder in children. J Neuropsychiatry Clin Neurosci 1991; 3:201-209
39. Shenker A. The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology. Adv Pediatr 1992;39:337-382
40. Mercugliano M. Neurotransmitter alterations in attention deficit-hyperactivity disorder. Mental Retardation and Developmental Disabilities. Research Reviews 1995;1:220-226
41. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997;121: 65-94
42. Bronowski J. Human and animal languages. To Honor Roman Jakobson, vol 1. The Hague, The Netherlands: Mouton and Co; 1967
43. Ernst M, Cohen RM, Liebenauer LL, et al. Am Acad Child Adolesc Psychiatry. In press